Bolt Biotherapeutics Reports First Quarter 2021 Financial Results and Provides Business Highlights

NEXT STORY
CymaBay Reports First Quarter 2021 Financial Results and Provides Corporate Update
PREV STORY
Kinnate Biopharma Inc. Closes $35 Million Series A Financing to Establish a Chinese Joint Venture
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Coherus BioSciences Announces New Employment Inducement Grants

author_avatar
NASDAQ Market News

Algernon Pharmaceuticals Appoints Professor of Respiratory Medicine Dr. Jacky Smith to Its Medical and Scientific Advisory Board

author_avatar
NASDAQ Market News

Sandoz reviewing options after Federal Circuit upholds lower court ruling in biosimilar Erelzi® case

author_avatar
NASDAQ Market News